欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/2561/001
药品名称Remifentanil Hospira 1 mg Pulver für ein Konzentrat zur Herstellung einer Injektions-/ Infusionslösu
活性成分
    • Remifentanil hydrochloride 1.1 mg
剂型Powder for concentrate for solution for infusion/injection
上市许可持有人Hospira Deutschland GmbH Rablstr. 24 D-81669 München
参考成员国 - 产品名称Germany (DE)
Biofenol 1 mg Pulver zur Herstellung einer Infusions-/Injektionslösung
互认成员国 - 产品名称
    • Iceland (IS)
    • Hungary (HU)
    • Romania (RO)
    • Poland (PL)
    • Ireland (IE)
    • Portugal (PT)
    • Norway (NO)
    • Slovenia (SI)
    • Estonia (EE)
    • Sweden (SE)
    • Slovakia (SK)
    • United Kingdom (Northern Ireland) (XI)
    • Italy (IT)
    • Cyprus (CY)
      BIOFENOL 1mg SOLUTION FOR INJECTION OR INFUSION
    • Malta (MT)
许可日期2010/12/09
最近更新日期2024/12/12
药物ATC编码
    • N01AH06 remifentanil
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Multiple (Copy) Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase